The global Topical Cannabis Pharmaceuticals Market, which are pharmaceuticals derived from cannabis, was valued at USD 6.84 billion in 2022 and is expected to grow to USD 1,356.78 billion by 2032 with a CAGR of 80% during the forecast period.